Posted on March 17, 2026
Short abstract:
Unity Insights and Health Innovation West of England were commissioned by Somerset, Wiltshire, Avon, and Gloucestershire (SWAG) Cancer Alliance to conduct an evaluation to assess the implementation of the capsule sponge test within Minchinhampton Surgery and Somer Valley Medical Group between November 2024 and October 2025. The capsule sponge test is a minimally invasive, non-endoscopic diagnostic method used to detect Barrett’s oesophagus and early oesophageal cancer in individuals with chronic reflux (EndoSign, 2026).
Overall, implementation of the capsule sponge test was seen as acceptable by patients and staff. Most patients had a positive experience and received enough information to decide whether to have the capsule sponge test. Staff recognised the importance of screening, valuing the simplicity of the capsule sponge test compared to an endoscopy. The recommendations provided would continue to promote safe and effective implementation of the capsule sponge test pathway.
Citation: Unity Insights and Health Innovation West of England, Capsule sponge test evaluation report; 2026 February
